Evidence and considerations in PrEP and PEP use
Building Skills in Sexual Health Series #9
National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) Presentation
Selected Abstracts from the 2023 CROI Conference
Update on PrEP guidelines for transgender patients
Review of the 2023 Perinatal HIV Guidelines related to infant feeding
Rationale and results of the DoxyPEP study/Implementation Considerations
Review of studies on HIV prevention, treatment and co-morbidities…
Broadly neutralizing antibodies as HIV therapy or prevention
An overview of harms caused by tobacco use alone and in combination with…
An overview of managing concommitent opioid use disorder and…
Update on long-acting Cabotegravir asPrEP, including lab testing and…
Discussion of HIV pre-exposure prophylaxis (PrEP) for persons who inject…
HIV transmission, prevention and treatment during pregnancy
Review of HIV prevention studies presented at the CROI 2022 conference
NAAT HIV testing for patients on PrEP
2021 USPHS/CDC HIV PrEP guidelines update
HIV testing considerations for people on CAB-LA for PrEP
How COVID adapatations may affect PrEP provision long-term